Talhia Tuck
Director/Board Member at TELOMIR PHARMACEUTICALS, INC.
Net worth: 273 222 $ as of 2024-03-30
Profile
Ms. Talhia T.
Tuck is an Independent Director at Telomir Pharmaceuticals, Inc. and a VP-Communications & Investor Relations at Rock Creek Pharmaceuticals, Inc. She is on the Board of Directors at Telomir Pharmaceuticals, Inc. Ms. Tuck was previously employed as an Independent Director by MIRA Pharmaceuticals, Inc., an Associate Director-Admissions by Georgetown University, and a VP-Communications & Investor Relations by Rock Creek Pharmaceuticals, Inc. She received her undergraduate degree from Harvard University and a graduate degree from Harvard Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-28 | 48,781 ( 0.16% ) | 251 222 $ | 2024-03-30 | |
| 2023-08-02 | 20,000 ( 0.14% ) | 22 000 $ | 2024-03-30 |
Talhia Tuck active positions
| Companies | Position | Start |
|---|---|---|
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 2022-10-31 |
Former positions of Talhia Tuck
| Companies | Position | End |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 2024-03-08 |
| Georgetown University | Corporate Officer/Principal | 2018-12-31 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Talhia Tuck
| Harvard University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| TELOMIR PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL. | Health Technology |
- Stock Market
- Insiders
- Talhia Tuck
